Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Lung-Yi Mak

Clin Mol Hepatol. 2024;30(2):171-173. Published online February 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0078

View: 972 Download: 46 Crossref: 1

Seogsong Jeong, Yohwan Lim, Su Kyoung Lee, Hyun Wook Han

Clin Mol Hepatol. 2023;29(3):810-811. Published online May 8, 2023

DOI: https://doi.org/10.3350/cmh.2023.0129

View: 1736 Download: 56 Web of Science: 1

Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim

Clin Mol Hepatol. 2021;27(2):221-235. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0239

View: 7844 Download: 353 Web of Science: 26 Crossref: 29

Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi

Received March 1, 2024 Accepted March 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0157 [Epub ahead of print]

View: 535 Download: 65

1 |

Viewed By 5394	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5361	MAFLD: How is it different from NAFLD?
Viewed By 5244	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3924	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3899	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search